Disparities in Acute Myeloid Leukemia

Acute myeloid leukemia is primarily a disease of older people with the average age of first diagnosis at 68 years old. Older patients may face many barriers to accessing care due to social determinants of health, including comorbidities, financial/insurance obstacles, transportation barriers, and inadequate caregiver support, which contribute to disparities and inequities in treatment and access.

ACCC’s Addressing Disparities in Access to Care for Acute Myeloid Leukemia program explores the current challenges in care coordination and therapy options for patients with acute myeloid leukemia and highlights strategies and best practices to improve outcomes for these patients.

Learning Objectives

• Identify barriers to receiving evidence-based treatment selection for acute myeloid leukemia
• Review approaches to improve oral oncolytic treatment adherence in patients with acute myeloid leukemia
• Employ strategies for the optimal management of treatment-related adverse events
• Implement solutions for improving care coordination between academic and community cancer centers to enable optimal management of patients, especially those from marginalized populations
• Explore patient-centric interventions for promoting treatment adherence and persistence, including ways to maximize the caregiver role

For more information about this project, please contact the ACCC Provider Education Department.